Iron Induces Cell Death and Strengthe... - Fight Prostate Ca...

Fight Prostate Cancer

2,875 members1,108 posts

Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models, Cinical Cancer Research, 2020 Dec 1

cujoe profile image
0 Replies

The following paper from 2020 might be of interest to those using the antiandrogen bicalutimide as a major component in their treatment programs. Much has been made of cancer cell death by ferroptosis and from this first paper it seems probable that there is some potential synergy between iron supplementation and bicalutamide. (Also linked is a more recent Nature review paper on ferroptosis in PCa):

The following passage is from the Discussion Section from the first paper:

* * *

Our results suggest that tumors with active androgen signaling might be intrinsically iron sensitive. We speculate that this would also be relevant for castration-resistant tumors where AR signaling is active, such as tumors characterized by abnormal AR overexpression or constitutively active mutated AR. Importantly, our results also show that castration-resistant tumors with inactive or absent androgen signaling pathway, like those lacking AR and/or characterized by neuroendocrine differentiation might be converted into iron sensitive by combining iron with antiandrogens.

Bicalutamide enhances the oxidative circuit initiated by iron

All prostate cancer cells proliferate less when exposed to bicalutamide–iron combination than when exposed to each single treatment. This effect is particularly evident in PC-3 cells, whose proliferation is barely impaired in vitro and unaffected in vivo by iron or bicalutamide alone. Although AR signaling is nonfunctional in PC-3 cells, high-dose bicalutamide mildly reduces PC-3 viability, suggesting that the androgen inhibitor has off-target effects that might intersect oxidative iron homeostasis, indirectly increasing iron toxicity. (emphasis added)

* * *

Links to both papers are below:

Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models, Cinical Cancer Research, 2020 Dec 1;26(23):6387-6398. Epub 2020 Sep 14.

aacrjournals.org/clincancer...

The role of ferroptosis in prostate cancer: a novel therapeutic strategy, Nature, Prostate Cancer and Prostatic Diseases, Review Article, Published: 02 September 2022.

nature.com/articles/s41391-...

Maybe us bical users need to also become Ironmen?

Stay S&W, Ciao - cujoe

Written by
cujoe profile image
cujoe
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 & 2 by the Androgen Receptor in Prostate Cancer - Endocrinology, April 2017

This 2017 research paper describes the inverse enzyme conversion that takes place in the conversion...

Prostate Cancer and Immunotherapy Breakout Session at the 2020 CRI Virtual Immunotherapy Patient Summit with introduction to my next post

Hello FPC members, This is a growing area of research in cancers as getting the body's immune...

Study Solves Testosterone’s Paradoxical Effects in Prostate Cancer, Duke Health, Published September 04, 2024

This research appears to be a major breakthrough in our understanding of PCa's development and...

My reaction to Crestor & Nubeqa combo. I need to make some adjustments. This study says simvastatin is best against APC. Your thoughts?

Based on these studies, do you think it's best to use simvastatin as your choice of statins? I'm...

Unmetabolized Estrogen (Depurinated Adducts) How I got PCa and how to prevent and detect it.

3 months before I got diagnosed with PCa in May of 2013 I had been feeling tired with no libido. I...